- Home
- FUSB vs ATNM Comparison
FUSB vs ATNM Comparison
Compare FUSB & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUSB
- ATNM
- Stock Information
- Founded
- FUSB 1952
- ATNM 2000
- Country
- FUSB United States
- ATNM United States
- Employees
- FUSB N/A
- ATNM N/A
- Industry
- FUSB Major Banks
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- FUSB Finance
- ATNM Health Care
- Exchange
- FUSB Nasdaq
- ATNM Nasdaq
- Market Cap
- FUSB 65.8M
- ATNM 56.5M
- IPO Year
- FUSB N/A
- ATNM N/A
- Fundamental
- Price
- FUSB $12.65
- ATNM $1.46
- Analyst Decision
- FUSB
- ATNM Strong Buy
- Analyst Count
- FUSB 0
- ATNM 5
- Target Price
- FUSB N/A
- ATNM $10.20
- AVG Volume (30 Days)
- FUSB 7.2K
- ATNM 245.2K
- Earning Date
- FUSB 10-24-2024
- ATNM 11-14-2024
- Dividend Yield
- FUSB 1.63%
- ATNM N/A
- EPS Growth
- FUSB 5.90
- ATNM N/A
- EPS
- FUSB 1.40
- ATNM N/A
- Revenue
- FUSB $40,310,000.00
- ATNM $81,000.00
- Revenue This Year
- FUSB N/A
- ATNM $186.10
- Revenue Next Year
- FUSB N/A
- ATNM $19,248.94
- P/E Ratio
- FUSB $8.76
- ATNM N/A
- Revenue Growth
- FUSB 0.79
- ATNM N/A
- 52 Week Low
- FUSB $8.66
- ATNM $1.33
- 52 Week High
- FUSB $12.65
- ATNM $10.24
- Technical
- Relative Strength Index (RSI)
- FUSB 64.00
- ATNM 33.81
- Support Level
- FUSB $12.20
- ATNM $1.38
- Resistance Level
- FUSB $12.65
- ATNM $1.97
- Average True Range (ATR)
- FUSB 0.38
- ATNM 0.11
- MACD
- FUSB 0.04
- ATNM -0.04
- Stochastic Oscillator
- FUSB 100.00
- ATNM 5.08
About FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals and other individuals.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.